(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

USO DE VALBENAZINA

Em AnáliseInvention PatentPCT · US2022073214

Application data

Number

112023026160

Type

Invention Patent

Filing

06/28/2022

Publication

03/05/2024

PCT

US2022073214

Progress at the INPI

  1. Filing06/28/22
  2. Publication
  3. Examination
  4. Allowance
  5. Grant
  6. In force

The application was filed at the INPI on 06/28/2022. It awaits formal examination and publication in the RPI gazette.

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 02/10/2026. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

NEUROCRINE BIOSCIENCES INC.

US

See this company's full portfolio

Inventors

G. L. (pessoa física)

US

Technical data

IPC Classification

Priority claims

US

63/216,877 · 06/30/2021

US

63/279,815 · 11/16/2021

US

63/298,291 · 01/11/2022

Abstract

VALBENAZINA PARA USO NO TRATAMENTO DE DISCINESIA DEVIDO À PARALISIA CEREBRAL. A presente invenção refere-se a um método para tratar a discinesia devido à paralisia cerebral em um paciente com necessidade do mesmo, compreendendo: administrar um inibidor do transportador vesicular de monoamina 2 (VMAT2) ao paciente com necessidade do mesmo.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Alteração de sede deferida

#25.7

02/10/2026

RPI 2875

Notificação de entrada na fase nacional - PCT

#1.3

03/05/2024

RPI 2774

Alteração de dados cadastrais

#1.1

12/19/2023

RPI 2763

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.